{
    "eid": "2-s2.0-85094101696",
    "title": "Slco1b1 and abcg2 gene polymorphisms in a thai population",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "ABCG2",
        "BRCP",
        "Drug transporters",
        "OATP1B1",
        "Pharmacogenetics",
        "Pharmacogenomics",
        "SLCO1B1"
    ],
    "authors": [
        "Punyabhorn Rattanacheeworn",
        "Monpat Chamnanphon",
        "Siriwan Thongthip",
        "Wonngarm Kittanamongkolchai",
        "Natavudh Townamchai",
        "Yingyos Avihingsanon",
        "Udomsak Udomnilobol",
        "Thomayant Prueksaritanont",
        "Suree Jianmongkol",
        "Pajaree Chariyavilaskul"
    ],
    "citedby-count": 5,
    "ref-count": 46,
    "ref-list": [
        "Drug transporters: their role and importance in the selection and development of new drugs",
        "The role of transporters in the pharmaco-kinetics of orally administered drugs",
        "Chapter 1 membrane transporters: fundamentals, function and their role in ADME",
        "Pharmacogenetics of Drug Transporters",
        "Impact of OATP transporters on pharma-cokinetics",
        "Chapter five-organic anion-transporting polypeptides",
        "Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, ator-vastatin and simvastatin acid in caucasian and asian subjects: a class effect?",
        "Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin",
        "The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin ther-apy",
        "ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin",
        "The clinical pharmaco-genetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
        "ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches",
        "Lack of effect of genetic poly-morphisms of SLCO1B1 on the lipid-lowering response to pitavas-tatin in Chinese patients",
        "Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans",
        "Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravas-tatin pharmacokinetics",
        "Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish popula-tion",
        "ABCG2 pharmacoge-netics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition",
        "ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations",
        "C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance",
        "Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder",
        "Association of genetic variations with pharmacokinetics and lipid-lowering response to ator-vastatin in healthy Korean subjects",
        "The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people",
        "Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1)",
        "SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid",
        "SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study",
        "The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15",
        "Role of Pharmacogenetics on Response to Statins: A Genotypebased Approach to Statin Therapy Outcome",
        "Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients",
        "ABCG2: a perspective",
        "Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvasta-tin, pravastatin and simvastatin",
        "Decreased extra-renal urate excretion is a common cause of hyperuricemia",
        "Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout",
        "Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2",
        "The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients",
        "ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout",
        "Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis",
        "The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperurice-mia of gout: the CONFIRMS trial",
        "Deviations from Hardy-Weinberg equilibrium in parental and unaffected sibling genotype data",
        "Pharmacogene variation in thai plasmodium vivax relapse patients treated with a combination of primaquine and chloroquine",
        "An association study of 43 SNPs in 16 candidate genes with atorvastatin response"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "HIV Netherlands Australia Thailand Research Collaboration",
        "Chulalongkorn University",
        "Health Systems Research Institute"
    ]
}